Dolby Laboratories (DLB)
Quick ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 701,893 | 698,566 | 626,551 | 520,821 | 577,752 | 741,636 | 709,535 | 656,816 | 745,364 | 765,079 | 688,443 | 626,158 | 620,127 | 858,905 | 900,393 | 1,056,690 | 1,225,380 | 1,219,650 | 1,104,570 | 1,110,020 |
| Short-term investments | US$ in thousands | 703 | 763 | — | — | 0 | 127,321 | 115,863 | 140,823 | 139,148 | 124,210 | 126,393 | 132,875 | 189,213 | 156,812 | 141,688 | 80,618 | 38,839 | 48,277 | 58,582 | 52,261 |
| Receivables | US$ in thousands | 331,096 | 501,995 | 544,466 | 560,196 | 512,943 | 476,646 | 525,301 | 510,787 | 444,375 | 459,450 | 558,577 | 505,520 | 419,686 | 406,631 | 486,109 | 468,258 | 414,925 | 441,664 | 516,884 | 481,487 |
| Total current liabilities | US$ in thousands | 437,790 | 388,785 | 457,485 | 441,877 | 417,836 | 354,536 | 442,902 | 394,096 | 422,226 | 423,036 | 314,011 | 290,447 | 277,518 | 285,485 | 280,959 | 283,290 | 315,717 | 308,965 | 308,977 | 316,419 |
| Quick ratio | 2.36 | 3.09 | 2.56 | 2.45 | 2.61 | 3.80 | 3.05 | 3.32 | 3.15 | 3.19 | 4.37 | 4.35 | 4.43 | 4.98 | 5.44 | 5.67 | 5.32 | 5.53 | 5.44 | 5.19 |
September 30, 2025 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($701,893K
+ $703K
+ $331,096K)
÷ $437,790K
= 2.36
Peer comparison
Sep 30, 2025
Company name
Symbol
Quick ratio
Dolby Laboratories
DLB
2.36
Aramark Holdings
ARMK
0.80
Copart Inc
CPRT
8.13
Maximus Inc
MMS
1.46
Unifirst Corporation
UNF
1.70